NCT00287209View on ClinicalTrials.gov

Reduction of Atrial Fibrillation Study in Patients Undergoing Coronary Artery Bypass Grafting. (RASCABG 1 Study)

PHASE4CompletedINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

August 31, 2005

Conditions

Atrial FibrillationCoronary Artery Bypass Grafting

Interventions

DRUG

Amiodarone

Trial Locations (1)

8200

Department of Cardiothoracic and Vascular Surgery & Institute of Clinical Medicine, Skejby Sygehus, Aarhus University Hospital, Aarhus N

All Listed Sponsors

lead

University of Aarhus

OTHER

NCT00287209 - Reduction of Atrial Fibrillation Study in Patients Undergoing Coronary Artery Bypass Grafting. (RASCABG 1 Study) | Biotech Hunter | Biotech Hunter